Awakn Life Sciences is a clinical stage biotechnology company developing therapeutics for substance use and mental health disorders. The company focuses on medications for Alcohol Use Disorder and aims to provide evidence-based treatments to addiction sufferers.

Awakn Life Sciences

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.

COM:AWAKNLIFESCIENCES

Awakn Life Sciences

Last Close

0.14

12/02 20:59

Market Cap

4.44M

Beta: -

Volume Today

7.32K

Avg: -

Analysis Not Available